tebu-bio signed recently a distribution agreement with HemaCare Corp. Built on a 36-year history in apheresis collection, HemaCare is a leader in cell and tissue collection and processing, providing high-quality biological material derived from normal and mobilized peripheral blood, bone marrow and cord blood that meets the unique needs of researchers, to ensure the quality research outcome they expect.

By signing this agreement with HemaCare, tebu-bio again broadens your sourcing possibilities. I am proud to say that, more than ever, our commitment to source the cell type that fits your needs is true. Really, I might hear you say? Yes, really! Let me explain why our offer is different from others.